lobbying_activities: 3375839

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3375839	4fff56ad-83fc-4791-97dd-562ed3eee966	Q2	ELITE STRATEGIC SERVICES	401108852	CONSERVATIVES FOR PROPERTY RIGHTS	2025	second_quarter	LBR	H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act)	HOUSE OF REPRESENTATIVES,SENATE	15000		0	0	2025-07-01T15:00:20-04:00